Synthesis, biological evaluation and molecular modeling study of pyrazole and pyrazoline derivatives as selective COX-2 inhibitors and anti-inflammatory agents. Part 2

Williams, 2002, Non-steroidal anti-inflammatory drugs, 751 Dannhardt, 2000, Eur. J. Med. Chem., 35, 499, 10.1016/S0223-5234(00)00150-1 Dubost, 1999, Rev. Med. Intern., 20, 171, 10.1016/S0248-8663(99)83037-9 Frank, 1991, Immunol. Today, 322, 12 Collier, 1971, Nature, 17, 232 Cryer, 1992, Arch. Intern. Med., 152, 1145, 10.1001/archinte.1992.00400180017003 Dannhardt, 2001, Eur. J. Med. Chem., 36, 109, 10.1016/S0223-5234(01)01197-7 Bayly, 1999, Bioorg. Med. Chem. Lett., 9, 307, 10.1016/S0960-894X(98)00717-3 Vane, 1971, Nat. New Biol., 231, 232, 10.1038/newbio231232a0 Buttar, 2000, Mayo Clin. Proc., 75, 1027, 10.4065/75.10.1027 Michaux, 2004, Mini Rev. Med. Chem., 4, 603, 10.2174/1389557043403756 Patel, 2010, J. Chem. Pharm. Res., 2, 73 Sakya, 2006, Bioorg. Med. Chem. Lett., 16, 288, 10.1016/j.bmcl.2005.10.006 Lehman, 2005, Curr. Top. Med. Chem., 5, 449, 10.2174/1568026054201703 Abdel-Aziz, 2011, Eur. J. Med. Chem., 46, 1648, 10.1016/j.ejmech.2011.02.013 Chakraborti, 2010, Curr. Med. Chem., 17, 1563, 10.2174/092986710790979980 Wang, 2010, Bioorg. Med. Chem. Lett., 20, 7159, 10.1016/j.bmcl.2010.07.054 Penning, 1997, J. Med. Chem., 40, 1347, 10.1021/jm960803q El-Sayed, 2011, Bioorg. Med. Chem., 19, 3416, 10.1016/j.bmc.2011.04.027 Jana, 2007, Tetrahedron Lett., 48, 4065, 10.1016/j.tetlet.2007.04.017 Das, N.B.; Mittra, A.S. Ind. J. Chem. 1978, 16b, 638. Azarifar, 2002, Molecules, 7, 885, 10.3390/71200885 Le‘vai, 2002, J. Heterocycl. Chem., 39, 1, 10.1002/jhet.5570390101 Levai, 2005, ARKIVOC, iv, 344, 10.3998/ark.5550190.0006.929 Azizian, 2006, ARKIVOC, xi, 47, 10.3998/ark.5550190.0007.b04 McGettigan, 2006, JAMA, 296, 1633, 10.1001/jama.296.13.jrv60011 El-Ayaan, 2007, Eur. J. Med. Chem., 42, 1325, 10.1016/j.ejmech.2007.02.014 Goda, 2005, Bioorg. Med. Chem., 13, 3175, 10.1016/j.bmc.2005.02.050 Lipinski, 2001, Adv. Drug Deliv. Rev., 46, 3, 10.1016/S0169-409X(00)00129-0 V-Life Molecular Design Suite 3.5, VLife Sciences Technologies Pvt. Ltd; www.Vlifesciences.com. Meade, 1993, J. Biol. Chem., 268, 6610, 10.1016/S0021-9258(18)53294-4 Kurumbail, 1996, Nature, 384, 644, 10.1038/384644a0 Llorens, 1999, Bioorg. Med. Chem. Lett., 9, 2779, 10.1016/S0960-894X(99)00481-3 Garavito, 1999, Biochem. Biophys. Acta, 1441, 278 MOE 2008.10 of Chemical Computing Group. Inc. El-Azab, 2010, Eur. J. Med. Chem., 45, 4188, 10.1016/j.ejmech.2010.06.013 Halgren, 1996, J. Comp. Chem., 17, 490, 10.1002/(SICI)1096-987X(199604)17:5/6<490::AID-JCC1>3.0.CO;2-P Sondhi, 2009, Bioorg. Med. Chem Lett., 19, 1534, 10.1016/j.bmcl.2008.07.048 Lima, 2002, Bioorg. Med. Chem., 10, 3067, 10.1016/S0968-0896(02)00152-9 Selinsky, 2001, Biochemistry, 40, 5172, 10.1021/bi010045s Fustero, 2008, J. Org. Chem., 73, 3523, 10.1021/jo800251g Singh, 2006, J. Heterocycl. Chem., 43, 1003, 10.1002/jhet.5570430428 Abdel-Aziz, 2011, Eur. J. Med. Chem., 46, 5487, 10.1016/j.ejmech.2011.09.011 Golbraikh, 2002, J. Mol. Graph. Model., 20, 269, 10.1016/S1093-3263(01)00123-1